跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
辅舒酮 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fluticasone Propionate Inhalation Aerosol
Approved
化学药品
Fluticasone Propionate Inhalation Aerosol
GLAXOSMITHKLINE SA
🇨🇳 National Medical Products Administration
Approval Date
Dec 27, 2023
Approval ID
8VIXybQb8Te
Company
GLAXOSMITHKLINE SA
Type
化学药品
Approval Details
Approval Id
8VIXybQb8Te
Approval Number
国药准字HJ20130190
Generic Name
丙酸氟替卡松吸入气雾剂
Generic Name En
Fluticasone Propionate Inhalation Aerosol
Trade Name
辅舒酮
Drug Type
化学药品
Dosage Form
吸入气雾剂
Strength
每瓶60揿,每揿含丙酸氟替卡松125μg,递送剂量为丙酸氟替卡松110μg;每瓶120揿,每揿含丙酸氟替卡松125μg,递送剂量为丙酸氟替卡松110μg
Reg Date
2023-12-27
Expired Date
2028-10-15
Company Name
GLAXOSMITHKLINE SA
Production Company Name
Glaxo Wellcome SA
Company Detail Path
/organization/glaxosmithkline-sa
Production Company Detail Path
/organization/glaxo-wellcome-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 27, 2023
Approval ID
8VIXybQb8Te
Type
化学药品
Back to NMPA Approvals